logo
  • About
  • Team
  • Portfolio
  • News
  • Contact
  • Search

Editor

Intuity Medical Closes $40M Series 3 Financing

by Editor

Backed by partners at Pfizer, eFFECTOR brings its VC total to $150M as PhII cancer trial looms

by Editor

ThreatMetrix Earns Sole Leader Position in New Risk-Based Authentication Report

by Editor

Insidesales.com Named to the Second Annual Forbes 2017 Cloud 100

by Editor

GE Healthcare, HeartFlow collaborate to tackle coronary artery disease

by Editor

How Apps Can Help Manage Chronic Diseases

by Editor

HeartFlow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board

by Editor

eFFECTOR, Pfizer, Merck KGaA Partner to Combine Avelumab with MNK1/2 Inhibitor

by Editor

Entelo steps up its AI game with $20M Series C

by Editor

Prevoty Introduces Autonomous Application Protection, Reports on Rapid Growth

by Editor

USVP
U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 500 companies spanning four decades, including: Box, Check Point Software, Guidewire, HeartFlow, HotelTonight, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Luminate, Omada Health, ON24, Pluto TV, Prevoty, Sequent, Silverback Therapeutics, ThreatMetrix, Trunk Club, Trusteer, Vontu, Yammer and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California.

©2022 U.S. Venture Partners. All Rights Reserved.
USVP and U.S. Venture Partners are registered trademarks of USVP Management Company LLC